Targeting autoimmune mechanisms by precision medicine in Myasthenia Gravis

Myasthenia Gravis (MG) is a chronic disabling autoimmune disease caused by autoantibodies to the neuromuscular junction (NMJ), characterized clinically by fluctuating weakness and early fatigability of ocular, skeletal and bulbar muscles. Despite being commonly considered a prototypic autoimmune dis...

Full description

Bibliographic Details

Main Authors:	Paola Cavalcante, Renato Mantegazza, Carlo Antozzi
Format:	Artigo
Language:	Inglês
Published:	Frontiers Media S.A. 2024-06-01
Series:	Frontiers in Immunology
Subjects:	Myasthenia Gravis autoimmunity B cells neonatal Fc receptor complement system precision medicine
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1404191/full
Tags:	Add Tag No Tags, Be the first to tag this record!